2023 annual financial data
Kyverna Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -62,406,000 USD and net income was -60,366,000 USD.
Operating cash flow was -52,410,000 USD.
Get free Kyverna Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -62,406,000 USD
- Net income
- -60,366,000 USD
- Operating cash flow
- -52,410,000 USD